ArticleClinical kidney journal2019

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Beatriz Fernandez-Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.